# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Katharine Hepburn (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML012-SYN
- Date: 2026-01-13
- Fictional facility: St. Posthumous Health Center
- Fictional author: Gwendolyn Price, MD
- Calendar frame: modern shifted

## What we are working on

- She wants people to stop assuming she has Parkinson's disease and wants to know what the tremor is **S**
- She wants to keep working on stage, where the voice tremor shows on sustained notes **S**

## Your goals

- Less hand tremor with daily tasks on a well-tolerated medicine, with resting heart rate 55 or above and no lightheadedness, by the three-month review. Target: 2026-05-05. Recorded outcome: TETRAS performance subscale fell from 22 to 16 and the activities of daily living subscale from 14 to 9 on propranolol; heart rate 64; no lightheadedness or falls. **S**
- Complete a course of voice therapy and use the strategies on stage. Target: 2026-05-05. Recorded outcome: Six-week course completed; steadier sustained notes with breath support and a slightly higher pitch. **S**
- Use adaptive aids for eating, drinking, and writing. Target: 2026-10-06. Recorded outcome: Occupational therapy evaluation completed after the six-month review; weighted utensils, a lidded travel cup, and a thicker pen in use. **S**
- Name a health care agent and record her goals of care by the annual wellness visit. Target: 2026-10-06. Recorded outcome: Health care agent named and goals of care recorded at the wellness visit. **S**

## What we agreed to do

- First-line medicine for limb tremor, chosen with movement disorders neurology: propranolol extended-release 60 mg each morning from the four-week visit; check resting heart rate and seated and standing blood pressure at every visit, ask about wheeze, fatigue, low mood, and lightheadedness, and do not stop it suddenly; primidone, started at 12.5 to 25 mg at bedtime, is held as the alternative or add-on, with checks for sedation, unsteadiness, and falls. Guideline: Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology (2011); Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology (2005); MDS evidence-based review of treatments for essential tremor (2019) **S**
- Movement disorders neurology consultation to confirm the diagnosis against the MDS consensus classification, choose treatment, and advise on head and voice tremor. Guideline: Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology (2011); Consensus Statement on the classification of tremors, from the task force on tremor of the International Parkinson and Movement Disorder Society (2018) **S**
- Speech-language therapy for voice tremor, and occupational therapy for adaptive aids (weighted utensils, lidded cups, thick-barreled pens). Guideline: Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology (2011); MDS evidence-based review of treatments for essential tremor (2019) **S**
- Monitor at every visit: TETRAS performance and daily-living subscales, spiral drawing and handwriting, heart rate and standing blood pressure on propranolol, side effects, falls, and drugs that worsen tremor; yearly: examination for signs beyond tremor, mood, cognition, and an AGS Beers Criteria medication review. Focused ultrasound thalamotomy or deep brain stimulation is considered only if disabling limb tremor persists after adequate trials of propranolol and primidone. Guideline: Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology (2011); Consensus Statement on the classification of tremors, from the task force on tremor of the International Parkinson and Movement Disorder Society (2018); A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor (2016); CMID: Clinical Monitoring Intelligence Database, general items for older adults (no essential tremor monograph) (2026) **S**
- Advance care planning: name a health care agent and record goals of care at the annual wellness visit. Guideline: CMID: Clinical Monitoring Intelligence Database, general items for older adults (no essential tremor monograph) (2026) **S**

## Follow-up

- 2026-01-13: Tremor evaluation: head, voice, and hand tremor; tremor rating, reversible causes, and functional impact **S**
- 2026-02-10: Four-week follow-up with movement disorders neurology consultation: diagnosis and choice of treatment **S**
- 2026-05-05: Three-month tremor review after starting propranolol and voice therapy **S**
- 2026-08-04: Six-month tremor review **S**
- 2026-10-06: Subsequent annual wellness visit **S**

This teaching document does not replace care from a qualified clinician.
